SMSamantha Mann

Samantha Mann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samantha Mann has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?

    by Arianna Paris, Laura Webster, Haralabos Eleftheriadis, Samantha Mann

    It remains unclear whether routine annual diabetic eye screening is still warranted for individuals aged 80 and over who show no signs of retinopathy at baseline. This study aimed to determine the incidence of referable diabetic retinopathy (DR) or diabetic maculopathy in individuals aged 80 years and older with no retinopathy at baseline in the South East London NHS Diabetic Eye Screening Programme (DESP), and to estimate the proportion requiring treatment. Data from the South East London DESP were linked with Hospital Eye Service (HES) records from 2009 to 2025. Individuals aged 80 years during 2009-2014 with no diabetic retinopathy or maculopathy (R0M0) at baseline and at least five years of follow-up were included. Screening and hospital data were analysed to determine referrals, diagnoses and treatments. Of 3599 eligible participants, 3258 (90.5%) had no referable diabetic retinopathy or diabetic maculopathy at final screening. In total, 532 (14.8%) were referred to HES, mainly for non-diabetic causes (56.6%). Referrals for sight-threatening diabetic retinopathy accounted for 89 cases (2.5%), and only four individuals (0.11%) required treatment, all for diabetic macular oedema. No cases of proliferative diabetic retinopathy were identified. Among people aged 80 years and older without diabetic retinopathy at baseline, the incidence of sight-threatening disease and treatment need were extremely low. Routine DESP recall in this population may offer limited clinical benefit and should be reconsidered within a risk-stratified screening framework.


  • Prospective randomized control trial measuring posterior capsular opacification rates and visual outcomes following insertion of two monofocal intraocular lenses: the hydrophobic RayOne 800C and the hydrophilic RayOne 600C: 12-month results

    by Khayam Naderi, Ashmal Jameel, Chun Fung Jeffrey Lam, Sancy Low, Vijay Wagh, Mani Bhogal, Ailsa Ritchie, Scott Robbie, Chris Hammond, Moin Mohamed, et al.

    To compare posterior capsular opacification (PCO) and visual outcomes between hydrophobic (HPB) and hydrophilic (HPL) acrylic intraocular lenses (IOLs) with comparable haptic shapes, dimensions, and the same manufacturer. Teaching Hospital in the United Kingdom. Single-centre, prospective, randomised control study. Patients with symptomatic cataract were randomised to receive either the RayOne 600C IOL (HPL group) (40 eyes, 40 patients) or the RayOne 800C IOL (HPB group) (45 eyes, 45 patients) and assessed at baseline, 1 month (1M), 6 months (6M), and 12 months (12M). Primary outcome measures were development of visually significant PCO requiring Nd: YAG laser capsulotomy, and the mean percentage area of PCO within the central 4 millimetres of the IOL as measured independently by three clinicians from retro-illuminated, digital photographs. Secondary outcomes were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), patient reported outcome measures (CATPROM-5, EQ5D3L) and adverse events. At 12M, there were no statistically significant differences in UDVA, CDVA, CATPROM-5, or EQ5D3L scores between the HPL and HPB groups. There were no patients requiring Nd: YAG laser capsulotomy for significant PCO in either group in the first 12 months after surgery. There were no differences in percentage areas of PCO between the HPL and HPB groups at 1M (2.05% vs 2.53%; p=0.18), 6M (1.92% vs 2.49%; p=0.22), and at 12M (3.64% vs 3.83%; p=0.86). There were no statistically significant differences in PCO or post-operative visual outcomes between a hydrophilic acrylic and a hydrophobic acrylic IOL with comparable designs.


  • Open Access

    Augmenting a prognostic deep learning system for referable diabetic retinopathy and maculopathy with synthetic retinal images

    by Paul Nderitu, Joan M. Nunez Do Rio, Laura Webster, Samantha S. Mann, David Hopkins, Christos Bergeles, Timothy L. Jackson

    Background: Labelled data scarcity and class imbalance are common deep learning system (DLS) development challenges. We investigated if synthetic retinal images from a conditional cascaded diffusion model (CCDM) improves prognostic DLS (pDLS) performance for 2-year incident referable diabetic retinopathy or maculopathy (rDR/rM) prediction. Methods: Macula images from 72,559 eyes (September 2013 to December 2019) from the UK South-East London Diabetic Eye Screening Programme (SEL-DESP) formed the development dataset, whilst 9,071 eyes were used for internal testing. Images from 2,842 eyes from Birmingham DESP were used for external testing. Prognostic DLS were augmented with ×1, ×2, and ×4 additional synthetic positive cases (pDLS-G) and compared to unaugmented (pDLS-N) and ×1 positive-case resampled pDLS (pDLS-R) using the Area-Under-the Receiver Operating Characteristic curve (AUROC). Results: Here we show that CCDM generate realistic synthetic retinal images that are comparable to real images and demonstrate the utility of synthetic retinal images in augmenting the development of a pDLS. The internal and external test AUROC for the pDLS are 0.827 (95% CI: 0.794–0.861) and 0.756 (0.680–0.831), respectively. Augmentation with ×2 additional synthetic positive cases (pDLS-G ×2) significantly improves the internal test AUROC to 0.845 (95% CI: 0.812–0.877, p = 0.044) but does not improve the external test AUROC 0.717 (0.633–0.828, p = 0.243). Resampling positive real cases alone does not improve pDLS-R performance. Conclusions: Augmenting pDLS with synthetic retinal images significantly improves pDLS performance on internal testing but not external testing suggesting further research is required to enhance the generalisability of synthetic retinal image augmentation.


  • Open Access

    A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk

    by Matilda Pitt, Abraham Olvera-Barrios, John Anderson, Louis Bolter, Ryan Chambers, Alasdair N. Warwick, Samantha Mann, Laura Webster, Jiri Fajtl, Sarah A. Barman, et al.

    Aims/hypothesis: Biennial, as opposed to annual, screening for diabetic retinopathy was recently introduced within England for those considered to be at ‘low risk’. This study aims to examine the impact that annual vs biennial screening has on equitable risk of diagnosis of sight-threatening diabetic retinopathy (STDR) among people at ‘low risk’ and to develop an amelioration protocol. Methods: In the North East London Diabetic Eye Screening Programme (NELDESP), 105,083 people without diabetic retinopathy were identified on two consecutive screening visits between January 2012 and September 2023. Data for these individuals were linked to electronic health records (EHR). Characteristics associated with subsequent STDR diagnosis were identified (including age, gender, ethnicity and diabetes duration), and logistic regression was performed to identify people who require annual screening, using variables available to the NELDESP and data from EHR. Simulations of the biennial screening protocol, and of protocols incorporating the outcomes of the logistic models and a simplified points model, were implemented, and the relative risk of STDR calculated at each screening appointment was compared amongst various population subgroups. The results were validated using data from the South East London DESP. Results: Among the low-risk participants, there were 3694 incident STDR cases over a mean duration of 5.0 years (SD 3.4 years). Under the biennial screening protocol, almost all groups had a significantly higher risk of STDR diagnosis compared with people aged 41 years or older who were of white ethnicity and had been living with diabetes for <10 years. Compared with biennial screening, a simplified screening protocol based on age, diabetes duration and ethnicity reduced the number of delayed STDR diagnoses from 39% to 25%, with a more equitable performance across population groups, and a modest impact on screening appointment numbers (46% vs 57% reduction in annual screening appointments, respectively). Conclusions/interpretation: A simple, clinically deliverable, personalised protocol for identifying who should be screened annually or biennially for diabetic eye disease would improve equity in risk of delayed STDR diagnosis per appointment. Graphical


  • Open Access

    Predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy using deep learning

    by Paul Nderitu, Joan M. Nunez Do Rio, Laura Webster, Samantha Mann, M. Jorge Cardoso, Marc Modat, David Hopkins, Christos Bergeles, Timothy L. Jackson

    Background: Predicting diabetic retinopathy (DR) progression could enable individualised screening with prompt referral for high-risk individuals for sight-saving treatment, whilst reducing screening burden for low-risk individuals. We developed and validated deep learning systems (DLS) that predict 1, 2 and 3 year emergent referable DR and maculopathy using risk factor characteristics (tabular DLS), colour fundal photographs (image DLS) or both (multimodal DLS). Methods: From 162,339 development-set eyes from south-east London (UK) diabetic eye screening programme (DESP), 110,837 had eligible longitudinal data, with the remaining 51,502 used for pretraining. Internal and external (Birmingham DESP, UK) test datasets included 27,996, and 6928 eyes respectively. Results: Internal multimodal DLS emergent referable DR, maculopathy or either area-under-the receiver operating characteristic (AUROC) were 0.95 (95% CI: 0.92–0.98), 0.84 (0.82–0.86), 0.85 (0.83–0.87) for 1 year, 0.92 (0.87–0.96), 0.84 (0.82–0.87), 0.85 (0.82–0.87) for 2 years, and 0.85 (0.80–0.90), 0.79 (0.76–0.82), 0.79 (0.76–0.82) for 3 years. External multimodal DLS emergent referable DR, maculopathy or either AUROC were 0.93 (0.88–0.97), 0.85 (0.80–0.89), 0.85 (0.76–0.85) for 1 year, 0.93 (0.89–0.97), 0.79 (0.74–0.84), 0.80 (0.76–0.85) for 2 years, and 0.91 (0.84–0.98), 0.79 (0.74–0.83), 0.79 (0.74–0.84) for 3 years. Conclusions: Multimodal and image DLS performance is significantly better than tabular DLS at all intervals. DLS accurately predict 1, 2 and 3 year emergent referable DR and referable maculopathy using colour fundal photographs, with additional risk factor characteristics conferring improvements in prognostic performance. Proposed DLS are a step towards individualised risk-based screening, whereby AI-assistance allows high-risk individuals to be closely monitored while reducing screening burden for low-risk individuals.


  • Open Access

    The risk of development and progression of diabetic retinopathy in a group of ethnically diverse pregnant women with diabetes attending three regional Diabetic Eye Screening Programs in the UK

    by Kirsty Clarke, Laura Webster, Susanne Althauser, John Anderson, Irene Stratton, Anna Brackenridge, Samantha S. Mann

    Background/Objectives: Currently, all pregnant women with diabetes are asked to attend screening at least twice during pregnancy, even if no retinopathy is detected in early pregnancy. We hypothesise that for women with no diabetic retinopathy in early pregnancy, the frequency of retinal screening may be safely reduced. Subjects/Methods: In this retrospective cohort study, data for 4718 pregnant women attending one of three UK Diabetic Eye Screening (DES) Programmes between July 2011 and October 2019 was extracted. The women’s UK DES grades at 13 weeks gestation (early pregnancy) and 28 weeks gestation (late pregnancy) were recorded. Descriptive statistics were used to report baseline data. Ordered logistic regression was used to control for covariates, such as age, ethnicity, diabetes duration, and diabetes type. Results: Of the women with grades recorded for both early and late pregnancy, a total of 3085 (65.39%) women had no retinopathy in early pregnancy, and 2306 (74.7%) of these women did not develop any retinopathy by 28 weeks. The number of women without retinopathy in early pregnancy who developed referable retinopathy was 14 (0.45%), none of whom required treatment. Diabetic Retinopathy in early pregnancy remained a significant predictor of DES grade in late pregnancy when covariates of Age, Ethnicity, and Diabetes Type were controlled for (P < 0.001). Conclusions: In summary, this study has demonstrated that the burden of managing diabetes for pregnant mothers may be safely reduced by limiting the number of diabetic eye screening appointments in women who have no retinal changes in early pregnancy. Screening of women with retinopathy in early pregnancy should continue in line with current UK guidance.


  • Open Access

    Incidental diagnosis of asymptomatic lipaemia retinalis in a patient with uncontrolled type 2 diabetes mellitus: ‘white lines’

    by Ghulam Mustafa Majeed, Clara Valor Suárez, Samantha Mann

    A man in his 60s presented for his medical retina clinic appointment, reporting increasing shortness of breath, aches and pains, and increasing insulin requirements during a difficult early lockdown. Wide-field colour fundus imaging (Optos Optomap) and an optical coherence tomography scan (Heidelberg Spectralis) revealed whitened and enlarged hyper-reflective vessels. Retinal colour photography also confirmed a creamy white discolouration of the vessels, which prompted the team to order a lipid profile. The profile showed a raised cholesterol level of 17.5 mmol/L (normal: <4mmol/L) and a marked elevated triglyceride level of 38.41 mmol/L (normal: <1.7 mmol/L). The clinical picture, alongside the biochemical results, suggested a diagnosis of secondary lipaemia retinalis due to poorly controlled diabetes. With aggressive treatment, the patient’s biochemistry and vessels returned to baseline. This rare condition should be taken as an indicator of a potential underlying life-threatening medical condition and the role an ophthalmologist has in initiating potential lifesaving intervention.

  • Effect of socioeconomic deprivation as determined by the English deprivation deciles on the progression of diabetic retinopathy and maculopathy: a multivariate case–control analysis of 88 910 patients attending a South-East London diabetic eye screening service

    by Periklis Giannakis, Paul Nderitu, Joan M Nunez Do Rio, Laura Webster, Samantha Mann, David Hopkins, Manuel Jorge Cardoso, Marc Modat, Christos Bergeles, Timothy L Jackson

    Purpose To determine associations between deprivation using the Index of Multiple Deprivation (IMD and individual IMD subdomains) with incident referable diabetic retinopathy/maculopathy (termed rDR). Methods Anonymised demographic and screening data collected by the South-East London Diabetic Eye Screening Programme were extracted from September 2013 to December 2019. Multivariable Cox proportional models were used to explore the association between the IMD, IMD subdomains and rDR. Results From 118 508 people with diabetes who attended during the study period, 88 910 (75%) were eligible. The mean (± SD) age was 59.6 (±14.7) years; 53.94% were male, 52.58% identified as white, 94.28% had type 2 diabetes and the average duration of diabetes was 5.81 (±6.9) years; rDR occurred in 7113 patients (8.00%). Known risk factors of younger age, Black ethnicity, type 2 diabetes, more severe baseline DR and diabetes duration conferred a higher risk of incident rDR. After adjusting for these known risk factors, the multivariable analysis did not show a significant association between IMD (decile 1 vs decile 10) and rDR (HR: 1.08, 95% CI: 0.87 to 1.34, p=0.511). However, high deprivation (decile 1) in three IMD subdomains was associated with rDR, namely living environment (HR: 1.64, 95% CI: 1.12 to 2.41, p=0.011), education skills (HR: 1.64, 95% CI: 1.12 to 2.41, p=0.011) and income (HR: 1.19, 95% CI: 1.02 to 1.38, p=0.024). Conclusion IMD subdomains allow for the detection of associations between aspects of deprivation and rDR, which may be missed when using the aggregate IMD. The generalisation of these findings outside the UK population requires corroboration internationally.